NO20005732L - Fenylsulfonamidfenyletylaminer anvendbare som dopaminreseptorer - Google Patents
Fenylsulfonamidfenyletylaminer anvendbare som dopaminreseptorerInfo
- Publication number
- NO20005732L NO20005732L NO20005732A NO20005732A NO20005732L NO 20005732 L NO20005732 L NO 20005732L NO 20005732 A NO20005732 A NO 20005732A NO 20005732 A NO20005732 A NO 20005732A NO 20005732 L NO20005732 L NO 20005732L
- Authority
- NO
- Norway
- Prior art keywords
- phenylethylamines
- phenylsulfonamide
- useful
- dopamine receptors
- alkyl
- Prior art date
Links
- 102000015554 Dopamine receptor Human genes 0.000 title 1
- 108050004812 Dopamine receptor Proteins 0.000 title 1
- GNLBKOISUOPBOL-UHFFFAOYSA-N benzenesulfonamide;2-phenylethanamine Chemical class NCCC1=CC=CC=C1.NS(=O)(=O)C1=CC=CC=C1 GNLBKOISUOPBOL-UHFFFAOYSA-N 0.000 title 1
- 125000006273 (C1-C3) alkyl group Chemical group 0.000 abstract 2
- 101100054666 Streptomyces halstedii sch3 gene Proteins 0.000 abstract 2
- 229910052736 halogen Inorganic materials 0.000 abstract 2
- 150000002367 halogens Chemical class 0.000 abstract 2
- 125000000956 methoxy group Chemical group [H]C([H])([H])O* 0.000 abstract 2
- 125000000876 trifluoromethoxy group Chemical group FC(F)(F)O* 0.000 abstract 2
- 125000002023 trifluoromethyl group Chemical group FC(F)(F)* 0.000 abstract 2
- 125000004209 (C1-C8) alkyl group Chemical group 0.000 abstract 1
- 102000004073 Dopamine D3 Receptors Human genes 0.000 abstract 1
- 108090000525 Dopamine D3 Receptors Proteins 0.000 abstract 1
- 208000015114 central nervous system disease Diseases 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C311/00—Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
- C07C311/22—Sulfonamides, the carbon skeleton of the acid part being further substituted by singly-bound oxygen atoms
- C07C311/29—Sulfonamides, the carbon skeleton of the acid part being further substituted by singly-bound oxygen atoms having the sulfur atom of at least one of the sulfonamide groups bound to a carbon atom of a six-membered aromatic ring
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C311/00—Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
- C07C311/15—Sulfonamides having sulfur atoms of sulfonamide groups bound to carbon atoms of six-membered aromatic rings
- C07C311/21—Sulfonamides having sulfur atoms of sulfonamide groups bound to carbon atoms of six-membered aromatic rings having the nitrogen atom of at least one of the sulfonamide groups bound to a carbon atom of a six-membered aromatic ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C311/00—Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
- C07C311/30—Sulfonamides, the carbon skeleton of the acid part being further substituted by singly-bound nitrogen atoms, not being part of nitro or nitroso groups
- C07C311/45—Sulfonamides, the carbon skeleton of the acid part being further substituted by singly-bound nitrogen atoms, not being part of nitro or nitroso groups at least one of the singly-bound nitrogen atoms being part of any of the groups, X being a hetero atom, Y being any atom, e.g. N-acylaminosulfonamides
- C07C311/46—Y being a hydrogen or a carbon atom
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Psychiatry (AREA)
- Psychology (AREA)
- Pain & Pain Management (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US8549398P | 1998-05-14 | 1998-05-14 | |
| PCT/US1999/007023 WO1999058499A1 (en) | 1998-05-14 | 1999-05-07 | Phenylsulfonamide-phenylethylamines useful as dopamine receptors |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| NO20005732D0 NO20005732D0 (no) | 2000-11-13 |
| NO20005732L true NO20005732L (no) | 2000-11-13 |
Family
ID=22191975
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO20005732A NO20005732L (no) | 1998-05-14 | 2000-11-13 | Fenylsulfonamidfenyletylaminer anvendbare som dopaminreseptorer |
Country Status (24)
| Country | Link |
|---|---|
| US (1) | US6103766A (de) |
| EP (1) | EP1077935B1 (de) |
| JP (1) | JP2002514623A (de) |
| KR (1) | KR20010043546A (de) |
| CN (1) | CN1152857C (de) |
| AT (1) | ATE253045T1 (de) |
| AU (1) | AU752543B2 (de) |
| BR (1) | BR9910405A (de) |
| CA (1) | CA2327345A1 (de) |
| DE (1) | DE69912419T2 (de) |
| DK (1) | DK1077935T3 (de) |
| EA (1) | EA002918B1 (de) |
| ES (1) | ES2211078T3 (de) |
| HU (1) | HUP0101746A3 (de) |
| IL (1) | IL139263A0 (de) |
| NO (1) | NO20005732L (de) |
| NZ (1) | NZ508152A (de) |
| PL (1) | PL343891A1 (de) |
| PT (1) | PT1077935E (de) |
| SK (1) | SK16242000A3 (de) |
| TR (1) | TR200003325T2 (de) |
| TW (1) | TW450954B (de) |
| WO (1) | WO1999058499A1 (de) |
| ZA (1) | ZA200005921B (de) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1998038156A1 (en) * | 1997-02-27 | 1998-09-03 | Takeda Chemical Industries, Ltd. | Amine compounds, their production and use as amyloid-beta production inhibitors |
| WO2002089740A2 (en) * | 2001-05-07 | 2002-11-14 | Smithkline Beecham Corporation | Sulfonamides |
| US6849635B2 (en) * | 2001-05-07 | 2005-02-01 | Smithkline Beecham Corporation | Sulfonamides |
| US7851463B2 (en) | 2004-10-14 | 2010-12-14 | Abbott Gmbh & Co. Kg | Heterocyclic compounds suitable for treating disorders that respond to modulation of the dopamine D3 receptor |
| JP4754570B2 (ja) | 2004-10-14 | 2011-08-24 | アボット ゲーエムベーハー ウント カンパニー カーゲー | ドーパミンｄ３受容体の調節に応答する障害の治療に好適なアザビシクロヘプチル化合物 |
| EP2371814A1 (de) * | 2004-10-14 | 2011-10-05 | Abbott GmbH & Co. KG | Aminoethylaromatische Verbindungen zur Behandlung von Erkrankungen, die auf Dopamin-D3-Rezeptormodulation ansprechen |
| UY30284A1 (es) | 2006-04-14 | 2007-11-30 | Abbott Gmbh & Amp | Compuestos de ariloxietilamina apropiados para tratar trastornos que responden a la modulacion del receptor de dopamina d3 |
| ES2360254T3 (es) * | 2006-04-14 | 2011-06-02 | ABBOTT GMBH & CO. KG | Compuestos de ariloxietilamina adecuados para tratamiento de trastornos que respondan a la modulación del receptor de dopamina d3. |
| TW200812961A (en) | 2006-04-19 | 2008-03-16 | Abbott Gmbh & Co Kg | Heterocyclic compounds suitable for treating disorders that respond to modulation of the serotonin 5HT6 receptor |
| TW200808762A (en) | 2006-04-19 | 2008-02-16 | Abbott Gmbh & Co Kg | Heterocyclic compounds suitable for treating disorders that respond to modulation of the serotonin 5HT6 receptor |
| WO2008026046A1 (en) * | 2006-08-30 | 2008-03-06 | Pfizer Products Inc. | Morpholine d3 dopamine antagonists |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3574741A (en) * | 1969-04-14 | 1971-04-13 | Mead Johnson & Co | Sulfonamidophenalkylamines |
| US5451677A (en) * | 1993-02-09 | 1995-09-19 | Merck & Co., Inc. | Substituted phenyl sulfonamides as selective β 3 agonists for the treatment of diabetes and obesity |
| GB9402197D0 (en) * | 1994-02-04 | 1994-03-30 | Smithkline Beecham Plc | Compounds |
| EP0793653A1 (de) * | 1994-11-23 | 1997-09-10 | Neurogen Corporation | Einige 4-aminomethyl-2-substituierte imidazolderivate und 2-aminomethyl - 4 - substituierte imidazolderivate; neue klassen von spezifischen liganden des dopaminrezeptorsubtyps |
| ES2191838T3 (es) * | 1996-05-11 | 2003-09-16 | Smithkline Beecham Plc | Derivados de tetrahidroisoquinoleina como moduladores de los receptores d3 de la dopamina. |
| EP1184370B1 (de) * | 1996-07-22 | 2005-09-14 | Novo Nordisk A/S | Verbindungen mit Wachstumshormon-freisetzenden Eigenschaften |
| JPH1180156A (ja) * | 1997-09-04 | 1999-03-26 | Hokuriku Seiyaku Co Ltd | １−（置換アリール）アルキル−１ｈ−イミダゾピリジン−４−アミン誘導体 |
-
1999
- 1999-04-26 TW TW088106644A patent/TW450954B/zh not_active IP Right Cessation
- 1999-05-07 AU AU37418/99A patent/AU752543B2/en not_active Ceased
- 1999-05-07 PL PL99343891A patent/PL343891A1/xx unknown
- 1999-05-07 BR BR9910405-9A patent/BR9910405A/pt not_active Application Discontinuation
- 1999-05-07 IL IL13926399A patent/IL139263A0/xx not_active IP Right Cessation
- 1999-05-07 EA EA200001184A patent/EA002918B1/ru not_active IP Right Cessation
- 1999-05-07 US US09/306,748 patent/US6103766A/en not_active Expired - Fee Related
- 1999-05-07 CN CNB998052175A patent/CN1152857C/zh not_active Expired - Fee Related
- 1999-05-07 CA CA002327345A patent/CA2327345A1/en not_active Abandoned
- 1999-05-07 NZ NZ508152A patent/NZ508152A/xx unknown
- 1999-05-07 HU HU0101746A patent/HUP0101746A3/hu unknown
- 1999-05-07 PT PT99919771T patent/PT1077935E/pt unknown
- 1999-05-07 WO PCT/US1999/007023 patent/WO1999058499A1/en not_active Ceased
- 1999-05-07 DE DE69912419T patent/DE69912419T2/de not_active Expired - Fee Related
- 1999-05-07 AT AT99919771T patent/ATE253045T1/de not_active IP Right Cessation
- 1999-05-07 SK SK1624-2000A patent/SK16242000A3/sk unknown
- 1999-05-07 EP EP99919771A patent/EP1077935B1/de not_active Expired - Lifetime
- 1999-05-07 KR KR1020007012661A patent/KR20010043546A/ko not_active Abandoned
- 1999-05-07 TR TR2000/03325T patent/TR200003325T2/xx unknown
- 1999-05-07 ES ES99919771T patent/ES2211078T3/es not_active Expired - Lifetime
- 1999-05-07 JP JP2000548303A patent/JP2002514623A/ja not_active Withdrawn
- 1999-05-07 DK DK99919771T patent/DK1077935T3/da active
-
2000
- 2000-10-23 ZA ZA200005921A patent/ZA200005921B/en unknown
- 2000-11-13 NO NO20005732A patent/NO20005732L/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| DE69912419D1 (de) | 2003-12-04 |
| US6103766A (en) | 2000-08-15 |
| HUP0101746A2 (hu) | 2002-03-28 |
| IL139263A0 (en) | 2001-11-25 |
| DK1077935T3 (da) | 2004-02-16 |
| ATE253045T1 (de) | 2003-11-15 |
| DE69912419T2 (de) | 2004-07-22 |
| AU752543B2 (en) | 2002-09-19 |
| PL343891A1 (en) | 2001-09-10 |
| ZA200005921B (en) | 2001-11-14 |
| PT1077935E (pt) | 2004-03-31 |
| EP1077935A1 (de) | 2001-02-28 |
| EA002918B1 (ru) | 2002-10-31 |
| CN1297431A (zh) | 2001-05-30 |
| TR200003325T2 (tr) | 2001-04-20 |
| ES2211078T3 (es) | 2004-07-01 |
| AU3741899A (en) | 1999-11-29 |
| CA2327345A1 (en) | 1999-11-18 |
| EA200001184A1 (ru) | 2001-04-23 |
| NO20005732D0 (no) | 2000-11-13 |
| SK16242000A3 (sk) | 2001-06-11 |
| KR20010043546A (ko) | 2001-05-25 |
| EP1077935B1 (de) | 2003-10-29 |
| WO1999058499A1 (en) | 1999-11-18 |
| TW450954B (en) | 2001-08-21 |
| HK1036049A1 (en) | 2001-12-21 |
| HUP0101746A3 (en) | 2002-10-28 |
| NZ508152A (en) | 2003-03-28 |
| BR9910405A (pt) | 2001-01-09 |
| CN1152857C (zh) | 2004-06-09 |
| JP2002514623A (ja) | 2002-05-21 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO20005732D0 (no) | Fenylsulfonamidfenyletylaminer anvendbare som dopaminreseptorer | |
| DK0923542T3 (da) | Arylsubstituerede cycliske aminer som selektive dopamin-D3-ligander | |
| ES2031513T3 (es) | Quinazolindionas y piridopirimidinadionas. | |
| NO973532L (no) | 2-aminoindaner som selektive dopamin D3-ligander | |
| AP2002002481A0 (en) | Biaryl ether derivatives useful as monoamine reuptake inhibitors. | |
| PE20031011A1 (es) | Derivados de dihidrobenzodiazepin-2-ona-iii | |
| YU56301A (sh) | Inhibitori resorpcije monoamina za tretiranje poremećaja cns | |
| PE20020911A1 (es) | Derivados de indol como agonistas de 5ht2 | |
| ES2128668T3 (es) | Agonistas del receptor de 5-ht4. | |
| FI943247A0 (fi) | Piperatsiinijohdannaisia 5-HT-reseptoriantagonisteina | |
| BR0109193A (pt) | Compostos com atividade agonista 5-ht2 e 5-ht1a para tratamento do glaucoma | |
| DE60014339D1 (de) | Aryl- und heteroaryl-kondensierte aminoalkyl-imidazol-derivate: selektive modulatoren der gabaa-rezeptoren | |
| HRP20000508B1 (hr) | Supstituirani 2-benzilamino-2-fenil-acetamidni spojevi | |
| PE20021003A1 (es) | Fenil-heterociclil-eteres como inhibidores selectivos de la recaptacion de serotonina (ssri) | |
| ATE157977T1 (de) | Chinoxalinderivate als eaa antagonisten | |
| PE20060632A1 (es) | Derivados de arilsulfonilestilbeno como antagonistas de los receptores 5-ht2a | |
| ES2182509T3 (es) | Derivados de n-ariloxietilamina para el tratamiento de la depresion. | |
| PE20040788A1 (es) | Derivados de indol con afinidad al receptor de androgeno | |
| ES2062495T3 (es) | Nuevos compuestos broncoespasmoliticos y procedimiento para su preparacion. | |
| HUP9800889A1 (hu) | Új naftil-piperazin-származékok | |
| PT1140919E (pt) | Novos derivados de ciclohexano 1,4-dissubstituido para o tratamento da depressao |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FC2A | Withdrawal, rejection or dismissal of laid open patent application |